These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 16109139

  • 21. [The role of calcium, calcitriol and their receptors in parathyroid regulation].
    Carrillo-López N, Fernández-Martín JL, Cannata-Andía JB.
    Nefrologia; 2009; 29(2):103-8. PubMed ID: 19396314
    [Abstract] [Full Text] [Related]

  • 22. The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism.
    Grzela T, Chudzinski W, Lasiecka Z, Niderla J, Wilczynski G, Gornicka B, Wasiutynski A, Durlik M, Boszczyk A, Brawura-Biskupski-Samaha R, Dziunycz P, Milewski L, Lazarczyk M, Lazarczyk M, Nawrot I.
    Int J Mol Med; 2006 May; 17(5):779-83. PubMed ID: 16596260
    [Abstract] [Full Text] [Related]

  • 23. Mechanisms of secondary hyperparathyroidism.
    Silver J, Kilav R, Naveh-Many T.
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
    [Abstract] [Full Text] [Related]

  • 24. Management of secondary hyperparathyroidism.
    Cunningham J.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S35-40. PubMed ID: 16109140
    [Abstract] [Full Text] [Related]

  • 25. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Kunimoto K, Okamoto M, Imazeki I, Muragaki Y, Akizawa T.
    Kidney Int; 2006 Aug; 70(3):486-95. PubMed ID: 16788697
    [Abstract] [Full Text] [Related]

  • 26. Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
    Sprague SM, Coyne D.
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):512-8. PubMed ID: 20133492
    [Abstract] [Full Text] [Related]

  • 27. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
    Shiizaki K, Negi S, Hatamura I, Sakaguchi T, Saji F, Kunimoto K, Mizobuchi M, Imazeki I, Ooshima A, Akizawa T.
    J Am Soc Nephrol; 2005 Jan; 16(1):97-108. PubMed ID: 15574509
    [Abstract] [Full Text] [Related]

  • 28. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
    Arcidiacono MV, Yang J, Fernandez E, Dusso A.
    Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851
    [Abstract] [Full Text] [Related]

  • 29. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency.
    Giannini S, Sella S, Silva Netto F, Cattelan C, Dalle Carbonare L, Lazzarin R, Marchini F, Rigotti P, Marcocci C, Cetani F, Pardi E, D'Angelo A, Realdi G, Bonfante L.
    J Bone Miner Res; 2010 Apr 01; 25(4):841-8. PubMed ID: 19839774
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
    Cozzolino M, Brancaccio D.
    Expert Opin Pharmacother; 2008 Apr 01; 9(6):947-54. PubMed ID: 18377338
    [Abstract] [Full Text] [Related]

  • 38. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.
    Cozzolino M, Ciceri P, Volpi EM, Olivi L, Messa PG.
    Blood Purif; 2009 Apr 01; 27(4):338-44. PubMed ID: 19295196
    [Abstract] [Full Text] [Related]

  • 39. Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay.
    Wada Y, Kunimura T, Sato S, Hisayuki T, Sato M, Imataka H, Yamashita N, Akizawa T, Moroboshi T.
    Ther Apher Dial; 2008 Aug 01; 12(4):319-28. PubMed ID: 18789120
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.